Daliom Biopharmaceuticals develops therapeutic proteins, such as monoclonal antibodies and recombinant proteins
Therapeutic proteins
Daliom Biopharmaceuticals develops therapeutic proteins, such as monoclonal antibodies and recombinant proteins, to treat a range of diseases. This includes immunotherapy for cancer, as well as treatments for autoimmune disorders, rare diseases, and infectious diseases.